"that misses milestone after milestone" I have been on board...

"that misses milestone after milestone"

I have been on board with "GDC-0084" from the begining. Name me one milestone they have missed. Granted in the last year or so some data has come out late....but that is not "missed". Let give you an example. GK of NOX told all shareholders that phase 3 registration trials for Veyonda would start in 2018. That is a "missed" milestone. KZA on the other hand has continued to surprise shareholders with ann after ann of new collaborations with hospitals wanting to start new trials.

All I have witness is a drug that has gone from strength to strength with trial after trial been sponsored by other parties. We have been on a free ride for most of the time as the work and millions of dollars have been carried by sponsors. If shareholders had to pay for all the trials the amount of CR would have been 20 times larger in size and cost.